(Total Views: 280)
Posted On: 04/06/2017 8:35:28 AM
Post# of 15624
I think it is important to know the value of this statement from the recent press release:
owcp: this is from their recent press release;
A wide and in-depth multi-layer clinical study on Psoriasis and psychological aspects is targeted to start next year, 2018, after collection of data from patients to carefully plan the targets of such a unique study that will show a combination of cannabinoids treatments for a specific disease. The study is carefully managed by Dr. Yehuda Baruch, the Company's CSO & Director of Research and Regulatory Affairs. Dr. Baruch comments, "We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments".
OK=notice the phrase "that will show a combination of cannabinoids treatments for a specific disease"
in my opinion only-this is what makes owcp's research and medical and scientific approach so superior...owcp will determine, based on a patient's individual needs, what treatment level is needed...
there are so many medical marijuana companies that sort of "throw something at the wall and see if it sticks"--bad analogy..but my point is: owcp will do VERY well due to their tremendous and outstanding approach both scientifically and medically... the ONE thing needed from an investor is PATIENCE and hold onto your shares... staying long....
owcp: this is from their recent press release;
A wide and in-depth multi-layer clinical study on Psoriasis and psychological aspects is targeted to start next year, 2018, after collection of data from patients to carefully plan the targets of such a unique study that will show a combination of cannabinoids treatments for a specific disease. The study is carefully managed by Dr. Yehuda Baruch, the Company's CSO & Director of Research and Regulatory Affairs. Dr. Baruch comments, "We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments".
OK=notice the phrase "that will show a combination of cannabinoids treatments for a specific disease"
in my opinion only-this is what makes owcp's research and medical and scientific approach so superior...owcp will determine, based on a patient's individual needs, what treatment level is needed...
there are so many medical marijuana companies that sort of "throw something at the wall and see if it sticks"--bad analogy..but my point is: owcp will do VERY well due to their tremendous and outstanding approach both scientifically and medically... the ONE thing needed from an investor is PATIENCE and hold onto your shares... staying long....
(1)
(0)
